Dr. Nguyen Tran, MD
Claim this profileMayo Clinic in Rochester
Studies Liver Cancer
Studies Skin Cancer
8 reported clinical trials
13 drugs studied
Area of expertise
1Liver Cancer
Stage IV
FGF19 positive
ATM positive
2Skin Cancer
Stage IV
FGF19 positive
Stage III
Affiliated Hospitals
Clinical Trials Nguyen Tran, MD is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
Ga 68 PSMA PET/CT Imaging
for Liver Cancer
This phase II trial tests whether 68-Gallium prostate specific membrane antigen (68Ga-PSMA) positron emission tomography (PET) imaging can improve the diagnosis and management of liver cancer that has spread to other parts of the body (advanced). PSMA is a protein that appears in large amounts on the surface of liver cancer cells. The radioactive chemical compound (68Ga-PSMA) has been designed to circulate through the body and attach itself to the PSMA protein on liver cancer cells. A PET scan is then used to detect the location of the tumor cells. 68Ga-PSMA PET may improve upon the diagnosis and management of liver cancer.
Recruiting1 award Phase 2
More about Nguyen Tran, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Nguyen Tran, MD has experience with
- Computed Tomography
- Gallium Ga 68 Gozetotide
- Positron Emission Tomography
- Futibatinib
- Pembrolizumab
- Olaparib
Breakdown of trials Nguyen Tran, MD has run
Liver Cancer
Skin Cancer
Hepatocellular Carcinoma
Biliary Tract Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nguyen Tran, MD specialize in?
Nguyen Tran, MD focuses on Liver Cancer and Skin Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are FGF19 positive.
Is Nguyen Tran, MD currently recruiting for clinical trials?
Yes, Nguyen Tran, MD is currently recruiting for 5 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Nguyen Tran, MD has studied deeply?
Yes, Nguyen Tran, MD has studied treatments such as Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography.
What is the best way to schedule an appointment with Nguyen Tran, MD?
Apply for one of the trials that Nguyen Tran, MD is conducting.
What is the office address of Nguyen Tran, MD?
The office of Nguyen Tran, MD is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.